Stocklytics Platform

Score (Market)

publish
The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions.
name
arrow_downwardScore languageValue languageQuality languageOwnership languageGrowth languageDividends languagePrice % Change
RVTY
RVTYRevvity
$123.98arrow_drop_up1.56%AI Analysis
Asset logo for symbol RKLB
RKLBRocket Lab USA
$7.46arrow_drop_down1.25%AI Analysis
Asset logo for symbol DNUT
DNUTKrispy Kreme
$11.44arrow_drop_down1.67%AI Analysis
Asset logo for symbol BHFAN
BHFANBrighthouse Financial
$20.59arrow_drop_up0.48%AI Analysis
Asset logo for symbol BLFY
BLFYBlue Foundry Bancorp
$10.60arrow_drop_down0.98%AI Analysis
Asset logo for symbol CTGO
CTGOContango Ore
$19.86arrow_drop_up4.25%AI Analysis
Asset logo for symbol PACK
PACKRanpak Holdings
$6.31arrow_drop_up0.31%AI Analysis
Asset logo for symbol LIXT
LIXTLixte Biotechnology Holdings
$1.83arrow_drop_down0.54%AI Analysis
Asset logo for symbol PTIX
PTIXProtagenic Therapeutics
$0.62arrow_drop_up5.08%AI Analysis
Asset logo for symbol CTRN
CTRNCiti Trends
$18.46arrow_drop_up0.43%AI Analysis
Asset logo for symbol LKCO
LKCOLuokung Technology
$2.69arrow_drop_up2.86%AI Analysis
Asset logo for symbol GNPX
GNPXGenprex
$0.40arrow_drop_down3.48%AI Analysis
Asset logo for symbol REPL
REPLReplimune Group
$11.22arrow_drop_up2.37%AI Analysis
Asset logo for symbol VOR
VORVor Biopharma
$0.78arrow_drop_down5.30%AI Analysis
Asset logo for symbol LGMK
LGMKLogicMark
$0.16arrow_drop_up7.14%AI Analysis
Asset logo for symbol KULR
KULRKULR Technology Group
$0.25arrow_drop_up3.92%AI Analysis
Asset logo for symbol AFRI
AFRIForafric Global PLC
$11.20arrow_drop_down1.40%AI Analysis
Asset logo for symbol BKSC
BKSCBank of South Carolina
$11.950.00%AI Analysis
Asset logo for symbol ASXC
ASXCAsensus Surgical
$0.35arrow_drop_up0.60%AI Analysis
Asset logo for symbol INZY
INZYInozyme Pharma
$5.19arrow_drop_down1.14%AI Analysis
Showing 4121-4140 of 4976
Results per page:

When making investment decisions, a holistic view is essential. The Stocklytics Score provides just that—ranking stocks based on five key factors to give you a comprehensive evaluation. With our Market Score, stocks are ordered by our proprietary scoring system, so you can quickly identify top opportunities. The Stocklytics Score is a powerful combination of: - Value Scoring – Find stocks that offer the best value based on fundamental metrics like price-to-earnings and price-to-sales ratios. - Quality Scoring – Invest with confidence by identifying high-quality companies with strong financials and consistent performance. - Ownership Scoring – Analyze institutional and insider ownership to get a sense of the confidence level from key stakeholders. - Growth Scoring – Discover companies with the potential for above-average earnings and revenue growth. - Dividends Scoring – Focus on stocks with strong dividend yields and sustainable payout ratios for long-term income generation. The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions. Why Use the Stocklytics Score? - Comprehensive View: Assess multiple factors at once to get a balanced perspective. - Data-Driven: Rely on a scoring system built from reliable financial data and market insights. - Actionable Rankings: Prioritize stocks based on their overall score or by individual factors like value or growth.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level